Cargando…
Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New Developments
Hepatoid adenocarcinoma of the stomach (HAS) is a rare malignant tumor, accounting for only 0.17–15% of gastric cancers. Patients are often diagnosed at an advanced disease stage, and their symptoms are similar to conventional gastric cancer (CGC) without specific clinical manifestation. Morphologic...
Autores principales: | Xia, Ruolan, Zhou, Yuwen, Wang, Yuqing, Yuan, Jiaming, Ma, Xuelei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071951/ https://www.ncbi.nlm.nih.gov/pubmed/33912455 http://dx.doi.org/10.3389/fonc.2021.633916 |
Ejemplares similares
-
Hepatoid adenocarcinoma of the stomach: CT findings
por: Yang, Qian, et al.
Publicado: (2023) -
Computed Tomography Features and Clinical Prognostic Characteristics of Hepatoid Adenocarcinoma of the Stomach
por: Huang, Wen-peng, et al.
Publicado: (2021) -
The Value of Perioperative Chemotherapy for Patients With Hepatoid Adenocarcinoma of the Stomach Undergoing Radical Gastrectomy
por: Zhou, Kai, et al.
Publicado: (2022) -
Clinicopathological and Prognostic Characteristics of Hepatoid Adenocarcinoma of the Stomach
por: Yang, Jinlin, et al.
Publicado: (2014) -
Early hepatoid adenocarcinoma of the stomach with signet ring cell carcinoma: A case report and clinicopathological features
por: Wu, Xinglong, et al.
Publicado: (2023)